Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1998-09-28
2000-02-01
Lambkin, Deborah C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514262, 514336, 514367, 514375, 514397, 514461, 544265, 5462834, 548170, 548222, 5483157, 549497, 549499, 549502, A61K 31505, A61K 3134, C07D40100, C07D27762
Patent
active
060203390
ABSTRACT:
The invention encompasses the novel compound of Formula I useful in the treatment of diseases, including asthma, by raising the level of cyclic adenosine-3',5'-monophosphate (cAMP) through the inhibition of phosphodiesterase IV (PDE IV). ##STR1## The invention also encompasses certain pharmaceutical compositions and methods for treatment of diseases by inhibition of PDE IV, resulting in an elevation of cAMP, comprising the use of compounds of Formula I.
REFERENCES:
patent: 2641601 (1953-06-01), Goldberg et al.
patent: 3222290 (1965-12-01), Braus et al.
patent: 3531497 (1970-09-01), Youngdale
patent: 3557005 (1971-01-01), Broaddus
patent: 3743656 (1973-07-01), Brown et al.
patent: 4595693 (1986-06-01), Biftu et al.
patent: 4927851 (1990-05-01), Damon, II et al.
patent: 5474995 (1995-12-01), Durcharme et al.
patent: 5602172 (1997-02-01), Boykin et al.
patent: 5629340 (1997-05-01), Kuwano et al.
Pouzet, P. et al. J. Chem. Soc. Chem. Commun. 1995 pp. 473-474.
Burger, K. et al. J. prakt. Chem. 334: 311-316 (1992).
Takahashi, K. et al. Bull. Chem. Soc. Jpn. 65: 1855-1859 (1992).
Rio, G. et al. Bull. Soc. Chim. France 12: 2824-2832 (1974.
Lutz, R.E. et al. J. Am. Chem. Soc. 64: 2583-2585 (1942).
Yates, P. et al. J. Am. Chem. Soc. 80: 196-201 (1958).
Hall, J.H. et al. J. Heterocycl. Chem. 29(5): 1245-1273 (1992).
Bailey, P.S. et al. J. Org. Chem. 21:297-302 (1956).
Watanabe, M. et al. Chem. Pharm. Bull. 37(11):2914-2919 (1989).
Das, B. P. et al. J. Med. Chem. 20(4):531-536 (1977).
Auterhoff, H. et al. Arch. Pharm. 299(7) 618-626 (1966). and Abstract.
Gump, K. et al. J. Am. Chem. Soc. 89(25): 6770-6771 (1967) with abstract.
Kumar, A. et al. Synth. Commun. 25(14): 2071-2078 (1995) with abstract.
Iyer, R. N. et al. Indian J. Chem. 11(12): 1260-1262 (1973) with abstract.
Traverso, V. G. Gass. Chil. Ital. 89: 1810-1817 (1959) with abstract.
Bayly Christopher
Giroux Andre
Han Yongxin
Mac Donald Dwight
Perrier Helene
Lambkin Deborah C.
Lee Shu M.
Merck & Co. , Inc.
Rose David L.
LandOfFree
Aryl furan derivatives as PDE IV inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aryl furan derivatives as PDE IV inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aryl furan derivatives as PDE IV inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-937735